Global Antibody Sales Market Report 2024
The global Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
The Antibody market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Antibody market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

Table of Content
1 Antibody Market Overview
1.1 Antibody Product Scope
1.2 Antibody Segment by Type
1.2.1 Global Antibody Sales by Type (2016 & 2021 & 2027)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody Segment by Application
1.3.1 Global Antibody Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Antibody Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antibody Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antibody Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antibody Price Trends (2016-2027)
2 Antibody Estimates and Forecasts by Region
2.1 Global Antibody Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antibody Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antibody Sales Market Share by Region (2016-2021)
2.2.2 Global Antibody Revenue Market Share by Region (2016-2021)
2.3 Global Antibody Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antibody Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antibody Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antibody Estimates and Projections (2016-2027)
2.4.2 Europe Antibody Estimates and Projections (2016-2027)
2.4.3 China Antibody Estimates and Projections (2016-2027)
2.4.4 Japan Antibody Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antibody Estimates and Projections (2016-2027)
2.4.6 India Antibody Estimates and Projections (2016-2027)
3 Global Antibody Competition Landscape by Players
3.1 Global Top Antibody Players by Sales (2016-2021)
3.2 Global Top Antibody Players by Revenue (2016-2021)
3.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody as of 2020)
3.4 Global Antibody Average Price by Company (2016-2021)
3.5 Manufacturers Antibody Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antibody Market Size by Type
4.1 Global Antibody Historic Market Review by Type (2016-2021)
4.1.1 Global Antibody Sales Market Share by Type (2016-2021)
4.1.2 Global Antibody Revenue Market Share by Type (2016-2021)
4.1.3 Global Antibody Price by Type (2016-2021)
4.2 Global Antibody Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antibody Sales Forecast by Type (2022-2027)
4.2.2 Global Antibody Revenue Forecast by Type (2022-2027)
4.2.3 Global Antibody Price Forecast by Type (2022-2027)
5 Global Antibody Market Size by Application
5.1 Global Antibody Historic Market Review by Application (2016-2021)
5.1.1 Global Antibody Sales Market Share by Application (2016-2021)
5.1.2 Global Antibody Revenue Market Share by Application (2016-2021)
5.1.3 Global Antibody Price by Application (2016-2021)
5.2 Global Antibody Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antibody Sales Forecast by Application (2022-2027)
5.2.2 Global Antibody Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibody Price Forecast by Application (2022-2027)
6 North America Antibody Market Facts & Figures
6.1 North America Antibody Sales by Company
6.1.1 North America Antibody Sales by Company (2016-2021)
6.1.2 North America Antibody Revenue by Company (2016-2021)
6.2 North America Antibody Sales Breakdown by Type
6.2.1 North America Antibody Sales Breakdown by Type (2016-2021)
6.2.2 North America Antibody Sales Breakdown by Type (2022-2027)
6.3 North America Antibody Sales Breakdown by Application
6.3.1 North America Antibody Sales Breakdown by Application (2016-2021)
6.3.2 North America Antibody Sales Breakdown by Application (2022-2027)
7 Europe Antibody Market Facts & Figures
7.1 Europe Antibody Sales by Company
7.1.1 Europe Antibody Sales by Company (2016-2021)
7.1.2 Europe Antibody Revenue by Company (2016-2021)
7.2 Europe Antibody Sales Breakdown by Type
7.2.1 Europe Antibody Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antibody Sales Breakdown by Type (2022-2027)
7.3 Europe Antibody Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Antibody Market Facts & Figures
8.1 China Antibody Sales by Company
8.1.1 China Antibody Sales by Company (2016-2021)
8.1.2 China Antibody Revenue by Company (2016-2021)
8.2 China Antibody Sales Breakdown by Type
8.2.1 China Antibody Sales Breakdown by Type (2016-2021)
8.2.2 China Antibody Sales Breakdown by Type (2022-2027)
8.3 China Antibody Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Antibody Market Facts & Figures
9.1 Japan Antibody Sales by Company
9.1.1 Japan Antibody Sales by Company (2016-2021)
9.1.2 Japan Antibody Revenue by Company (2016-2021)
9.2 Japan Antibody Sales Breakdown by Type
9.2.1 Japan Antibody Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antibody Sales Breakdown by Type (2022-2027)
9.3 Japan Antibody Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Antibody Market Facts & Figures
10.1 Southeast Asia Antibody Sales by Company
10.1.1 Southeast Asia Antibody Sales by Company (2016-2021)
10.1.2 Southeast Asia Antibody Revenue by Company (2016-2021)
10.2 Southeast Asia Antibody Sales Breakdown by Type
10.2.1 Southeast Asia Antibody Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antibody Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antibody Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Antibody Market Facts & Figures
11.1 India Antibody Sales by Company
11.1.1 India Antibody Sales by Company (2016-2021)
11.1.2 India Antibody Revenue by Company (2016-2021)
11.2 India Antibody Sales Breakdown by Type
11.2.1 India Antibody Sales Breakdown by Type (2016-2021)
11.2.2 India Antibody Sales Breakdown by Type (2022-2027)
11.3 India Antibody Sales Breakdown by Application
11.3.1 India Antibody Sales Breakdown by Application (2016-2021)
11.3.2 India Antibody Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Antibody Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Antibody Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Antibody Products Offered
12.1.5 Roche Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Antibody Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Antibody Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Antibody Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Antibody Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Antibody Products Offered
12.4.5 Novartis Recent Development
12.5 AbbVie
12.5.1 AbbVie Corporation Information
12.5.2 AbbVie Business Overview
12.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AbbVie Antibody Products Offered
12.5.5 AbbVie Recent Development
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Business Overview
12.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amgen Antibody Products Offered
12.6.5 Amgen Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Antibody Products Offered
12.7.5 Pfizer Recent Development
12.8 Bayer
12.8.1 Bayer Corporation Information
12.8.2 Bayer Business Overview
12.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bayer Antibody Products Offered
12.8.5 Bayer Recent Development
12.9 Lilly
12.9.1 Lilly Corporation Information
12.9.2 Lilly Business Overview
12.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lilly Antibody Products Offered
12.9.5 Lilly Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Corporation Information
12.10.2 Bristol-Myers Squibb Business Overview
12.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bristol-Myers Squibb Antibody Products Offered
12.10.5 Bristol-Myers Squibb Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Business Overview
12.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Antibody Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Biogen
12.12.1 Biogen Corporation Information
12.12.2 Biogen Business Overview
12.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biogen Antibody Products Offered
12.12.5 Biogen Recent Development
12.13 AstraZeneca
12.13.1 AstraZeneca Corporation Information
12.13.2 AstraZeneca Business Overview
12.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2016-2021)
12.13.4 AstraZeneca Antibody Products Offered
12.13.5 AstraZeneca Recent Development
12.14 Sanofi
12.14.1 Sanofi Corporation Information
12.14.2 Sanofi Business Overview
12.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sanofi Antibody Products Offered
12.14.5 Sanofi Recent Development
12.15 Alexion Pharmaceuticals
12.15.1 Alexion Pharmaceuticals Corporation Information
12.15.2 Alexion Pharmaceuticals Business Overview
12.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Alexion Pharmaceuticals Antibody Products Offered
12.15.5 Alexion Pharmaceuticals Recent Development
12.16 Seattle Genetics
12.16.1 Seattle Genetics Corporation Information
12.16.2 Seattle Genetics Business Overview
12.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Seattle Genetics Antibody Products Offered
12.16.5 Seattle Genetics Recent Development
13 Antibody Manufacturing Cost Analysis
13.1 Antibody Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibody
13.4 Antibody Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibody Distributors List
14.3 Antibody Customers
15 Market Dynamics
15.1 Antibody Market Trends
15.2 Antibody Drivers
15.3 Antibody Market Challenges
15.4 Antibody Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer